Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

NCT06005012 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT06005012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06005012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 25, 2023
Completion date
December 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, liver, non-alcoholic fatty liver disease, type 2 diabetes mellitus in obese